Easy Access and Express Report Delivery Service
Immune Globulins Market, Global Outlook and Forecast 2024-2030
Report ID
46656
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
118
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Immune Globulins market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Immune Globulins market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Immune Globulins, challenges faced by the industry, and potential opportunities for market players. The global Immune Globulins market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Immune Globulins market presents opportunities for various stakeholders, including Immunodeficiency, Autoimmune Disease. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Immune Globulins market. Additionally, the growing consumer demand present avenues for market expansion. The global Immune Globulins market was valued at US$ 14360 million in 2023 and is projected to reach US$ 24420 million by 2030, at a CAGR of 7.9% during the forecast period. The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach. Key Features: The research report on the Immune Globulins market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Immune Globulins market. Market Overview: The report provides a comprehensive overview of the Immune Globulins market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., IVIg Liquid, IVIg Powder), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Immune Globulins market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Immune Globulins market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Immune Globulins market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Immune Globulins market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Immune Globulins market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Immune Globulins market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Immune Globulins, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Immune Globulins market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Immune Globulins market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Market segment by Type
- IVIg Liquid
- IVIg Powder
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- US
- Canada
- Mexico
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- Brazil
- Argentina
- Rest of South America
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
- Takeda
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
-
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Immune Globulins Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Immune Globulins Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Immune Globulins Overall Market Size 2.1 Global Immune Globulins Market Size: 2023 VS 2030 2.2 Global Immune Globulins Revenue, Prospects & Forecasts: 2019-2030 2.3 Global Immune Globulins Sales: 2019-2030 3 Company Landscape 3.1 Top Immune Globulins Players in Global Market 3.2 Top Global Immune Globulins Companies Ranked by Revenue 3.3 Global Immune Globulins Revenue by Companies 3.4 Global Immune Globulins Sales by Companies 3.5 Global Immune Globulins Price by Manufacturer (2019-2024) 3.6 Top 3 and Top 5 Immune Globulins Companies in Global Market, by Revenue in 2023 3.7 Global Manufacturers Immune Globulins Product Type 3.8 Tier 1, Tier 2 and Tier 3 Immune Globulins Players in Global Market 3.8.1 List of Global Tier 1 Immune Globulins Companies 3.8.2 List of Global Tier 2 and Tier 3 Immune Globulins Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global Immune Globulins Market Size Markets, 2023 & 2030 4.1.2 IVIg Liquid 4.1.3 IVIg Powder 4.2 By Type - Global Immune Globulins Revenue & Forecasts 4.2.1 By Type - Global Immune Globulins Revenue, 2019-2024 4.2.2 By Type - Global Immune Globulins Revenue, 2025-2030 4.2.3 By Type - Global Immune Globulins Revenue Market Share, 2019-2030 4.3 By Type - Global Immune Globulins Sales & Forecasts 4.3.1 By Type - Global Immune Globulins Sales, 2019-2024 4.3.2 By Type - Global Immune Globulins Sales, 2025-2030 4.3.3 By Type - Global Immune Globulins Sales Market Share, 2019-2030 4.4 By Type - Global Immune Globulins Price (Manufacturers Selling Prices), 2019-2030 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Immune Globulins Market Size, 2023 & 2030 5.1.2 Immunodeficiency 5.1.3 Autoimmune Disease 5.1.4 Acute Infection 5.2 By Application - Global Immune Globulins Revenue & Forecasts 5.2.1 By Application - Global Immune Globulins Revenue, 2019-2024 5.2.2 By Application - Global Immune Globulins Revenue, 2025-2030 5.2.3 By Application - Global Immune Globulins Revenue Market Share, 2019-2030 5.3 By Application - Global Immune Globulins Sales & Forecasts 5.3.1 By Application - Global Immune Globulins Sales, 2019-2024 5.3.2 By Application - Global Immune Globulins Sales, 2025-2030 5.3.3 By Application - Global Immune Globulins Sales Market Share, 2019-2030 5.4 By Application - Global Immune Globulins Price (Manufacturers Selling Prices), 2019-2030 6 Sights by Region 6.1 By Region - Global Immune Globulins Market Size, 2023 & 2030 6.2 By Region - Global Immune Globulins Revenue & Forecasts 6.2.1 By Region - Global Immune Globulins Revenue, 2019-2024 6.2.2 By Region - Global Immune Globulins Revenue, 2025-2030 6.2.3 By Region - Global Immune Globulins Revenue Market Share, 2019-2030 6.3 By Region - Global Immune Globulins Sales & Forecasts 6.3.1 By Region - Global Immune Globulins Sales, 2019-2024 6.3.2 By Region - Global Immune Globulins Sales, 2025-2030 6.3.3 By Region - Global Immune Globulins Sales Market Share, 2019-2030 6.4 North America 6.4.1 By Country - North America Immune Globulins Revenue, 2019-2030 6.4.2 By Country - North America Immune Globulins Sales, 2019-2030 6.4.3 US Immune Globulins Market Size, 2019-2030 6.4.4 Canada Immune Globulins Market Size, 2019-2030 6.4.5 Mexico Immune Globulins Market Size, 2019-2030 6.5 Europe 6.5.1 By Country - Europe Immune Globulins Revenue, 2019-2030 6.5.2 By Country - Europe Immune Globulins Sales, 2019-2030 6.5.3 Germany Immune Globulins Market Size, 2019-2030 6.5.4 France Immune Globulins Market Size, 2019-2030 6.5.5 U.K. Immune Globulins Market Size, 2019-2030 6.5.6 Italy Immune Globulins Market Size, 2019-2030 6.5.7 Russia Immune Globulins Market Size, 2019-2030 6.5.8 Nordic Countries Immune Globulins Market Size, 2019-2030 6.5.9 Benelux Immune Globulins Market Size, 2019-2030 6.6 Asia 6.6.1 By Region - Asia Immune Globulins Revenue, 2019-2030 6.6.2 By Region - Asia Immune Globulins Sales, 2019-2030 6.6.3 China Immune Globulins Market Size, 2019-2030 6.6.4 Japan Immune Globulins Market Size, 2019-2030 6.6.5 South Korea Immune Globulins Market Size, 2019-2030 6.6.6 Southeast Asia Immune Globulins Market Size, 2019-2030 6.6.7 India Immune Globulins Market Size, 2019-2030 6.7 South America 6.7.1 By Country - South America Immune Globulins Revenue, 2019-2030 6.7.2 By Country - South America Immune Globulins Sales, 2019-2030 6.7.3 Brazil Immune Globulins Market Size, 2019-2030 6.7.4 Argentina Immune Globulins Market Size, 2019-2030 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Immune Globulins Revenue, 2019-2030 6.8.2 By Country - Middle East & Africa Immune Globulins Sales, 2019-2030 6.8.3 Turkey Immune Globulins Market Size, 2019-2030 6.8.4 Israel Immune Globulins Market Size, 2019-2030 6.8.5 Saudi Arabia Immune Globulins Market Size, 2019-2030 6.8.6 UAE Immune Globulins Market Size, 2019-2030 7 Manufacturers & Brands Profiles 7.1 Takeda 7.1.1 Takeda Company Summary 7.1.2 Takeda Business Overview 7.1.3 Takeda Immune Globulins Major Product Offerings 7.1.4 Takeda Immune Globulins Sales and Revenue in Global (2019-2024) 7.1.5 Takeda Key News & Latest Developments 7.2 Grifols 7.2.1 Grifols Company Summary 7.2.2 Grifols Business Overview 7.2.3 Grifols Immune Globulins Major Product Offerings 7.2.4 Grifols Immune Globulins Sales and Revenue in Global (2019-2024) 7.2.5 Grifols Key News & Latest Developments 7.3 CSL 7.3.1 CSL Company Summary 7.3.2 CSL Business Overview 7.3.3 CSL Immune Globulins Major Product Offerings 7.3.4 CSL Immune Globulins Sales and Revenue in Global (2019-2024) 7.3.5 CSL Key News & Latest Developments 7.4 Octapharma 7.4.1 Octapharma Company Summary 7.4.2 Octapharma Business Overview 7.4.3 Octapharma Immune Globulins Major Product Offerings 7.4.4 Octapharma Immune Globulins Sales and Revenue in Global (2019-2024) 7.4.5 Octapharma Key News & Latest Developments 7.5 Biotest 7.5.1 Biotest Company Summary 7.5.2 Biotest Business Overview 7.5.3 Biotest Immune Globulins Major Product Offerings 7.5.4 Biotest Immune Globulins Sales and Revenue in Global (2019-2024) 7.5.5 Biotest Key News & Latest Developments 7.6 Kedrion 7.6.1 Kedrion Company Summary 7.6.2 Kedrion Business Overview 7.6.3 Kedrion Immune Globulins Major Product Offerings 7.6.4 Kedrion Immune Globulins Sales and Revenue in Global (2019-2024) 7.6.5 Kedrion Key News & Latest Developments 7.7 Hualan Bio 7.7.1 Hualan Bio Company Summary 7.7.2 Hualan Bio Business Overview 7.7.3 Hualan Bio Immune Globulins Major Product Offerings 7.7.4 Hualan Bio Immune Globulins Sales and Revenue in Global (2019-2024) 7.7.5 Hualan Bio Key News & Latest Developments 7.8 CNBG 7.8.1 CNBG Company Summary 7.8.2 CNBG Business Overview 7.8.3 CNBG Immune Globulins Major Product Offerings 7.8.4 CNBG Immune Globulins Sales and Revenue in Global (2019-2024) 7.8.5 CNBG Key News & Latest Developments 7.9 Shanghai RAAS 7.9.1 Shanghai RAAS Company Summary 7.9.2 Shanghai RAAS Business Overview 7.9.3 Shanghai RAAS Immune Globulins Major Product Offerings 7.9.4 Shanghai RAAS Immune Globulins Sales and Revenue in Global (2019-2024) 7.9.5 Shanghai RAAS Key News & Latest Developments 7.10 CBPO 7.10.1 CBPO Company Summary 7.10.2 CBPO Business Overview 7.10.3 CBPO Immune Globulins Major Product Offerings 7.10.4 CBPO Immune Globulins Sales and Revenue in Global (2019-2024) 7.10.5 CBPO Key News & Latest Developments 7.11 LFB Group 7.11.1 LFB Group Company Summary 7.11.2 LFB Group Business Overview 7.11.3 LFB Group Immune Globulins Major Product Offerings 7.11.4 LFB Group Immune Globulins Sales and Revenue in Global (2019-2024) 7.11.5 LFB Group Key News & Latest Developments 7.12 BPL 7.12.1 BPL Company Summary 7.12.2 BPL Business Overview 7.12.3 BPL Immune Globulins Major Product Offerings 7.12.4 BPL Immune Globulins Sales and Revenue in Global (2019-2024) 7.12.5 BPL Key News & Latest Developments 7.13 Sichuan Yuanda Shuyang 7.13.1 Sichuan Yuanda Shuyang Company Summary 7.13.2 Sichuan Yuanda Shuyang Business Overview 7.13.3 Sichuan Yuanda Shuyang Immune Globulins Major Product Offerings 7.13.4 Sichuan Yuanda Shuyang Immune Globulins Sales and Revenue in Global (2019-2024) 7.13.5 Sichuan Yuanda Shuyang Key News & Latest Developments 8 Global Immune Globulins Production Capacity, Analysis 8.1 Global Immune Globulins Production Capacity, 2019-2030 8.2 Immune Globulins Production Capacity of Key Manufacturers in Global Market 8.3 Global Immune Globulins Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Immune Globulins Supply Chain Analysis 10.1 Immune Globulins Industry Value Chain 10.2 Immune Globulins Upstream Market 10.3 Immune Globulins Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Immune Globulins Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer
-
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
